发明名称 Antiinflammatory pregnene-diones
摘要 Trihydroxypregnene-3,20-diones (I) and especially 11 beta, 17 alpha, 21-trihydroxy-15, 16 beta-methylene-pregnene (4)-(and pregna-1,4-diene)-3,20-dione, for use as anti-inflammatories. R6 and R9 independently are H, halogen, R17, R21 independently are OH or O-acyl; Z is CO or beta-CH2OH. Preparation of (I) and 1,2-dehydro-deriv. by numerous methods e.g. (a) microbiological 11-hydroxylation of (I) (Z=CH2); (b) 1,2-dehydrogenation of a cmpd. (I); (c) adding HOCl or HOBr to the 9,11-double bond a cmpd. (I) or its, 1,2-dehydro-derivs. (Z = HC). In an example 11 beta, 17 alpha-21-trihydroxy-15,16 beta-methylene-pregnene (4)-3,20-dione, m.p. 219-221 degrees is obtained by microbiological hydroxylation of 17 alpha, 21-dihydroxy-15,16 beta-methylene-pregnene (4)-3,20-dione using Coniothyrium hellebori as organism.
申请公布号 CH531493(A) 申请公布日期 1972.12.15
申请号 CH19720008603 申请日期 1969.12.17
申请人 F. HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT 发明人 FUERST,ANDOR,DR.;MUELLER,MARCEL,DR.;MUELLER,PETER,DR.;JOHANNES,DR. SCHOCHER,ARNO;BECHER,ELISABETH
分类号 G01D1/04;C07J53/00;C07J75/00;C12P33/08;G01D9/00;G01D9/16;G01D9/30;G01D18/00;G07C3/12;G07C3/14;G07C11/00;G08G1/01 主分类号 G01D1/04
代理机构 代理人
主权项
地址